Effect of non-surgical periodontal therapy on saliva levels of paraoxonase-1 in healthy and periodontitis subjects: a clinico-biochemical study
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20232030Keywords:
High-density lipoproteins, Paraoxonase, Periodontitis, Reactive oxygen speciesAbstract
Background: Salivary antioxidants play main roles in the defensive mechanism of saliva against free radicals. Prevalence of inflammatory conditions like periodontitis associated with several pathogeneses, knowing the defensive mechanism of salivary antioxidant against free radicals can provide helpful strategies in diagnosis and evaluation of these conditions. The aim of this study was evaluation of the paraoxonase (PON1) levels of saliva in healthy and periodontitis subjects.
Methods: In this clinico-biochemical study 30 patients diagnosed with periodontitis and 30 healthy controls aged between 18 to 60 years, 30 patients were recalled after non-surgical periodontal therapy were selected. Three millilitres (3 ml) of whole unstimulated saliva sample were collected. PON-1 level were determined by a commercially available enzyme-linked immunosorbent assay (ELISA) kit.
Results: The results showed a statistically significant difference in the salivary PON1 levels in pre (66.6600%) and post (89.3200%) treatment samples (p value <0.001). The saliva level of PON1 was improved compared to post treatment. There was an improvement in the clinical parameters, and seen a statistically significant difference with p=0.001.
Conclusions: The reduction in the saliva levels of paraoxonase in periodontitis patients has led to a variation leading to increased ROS and therefore periodontal breakdown. The variation in salivary paraoxonase levels before and after treatment can be taken as an indicator of success of periodontal therapy.
Metrics
References
Masumoto R, Kitagaki J, Matsumoto M, Miyauchi S, Fujihara C, Yamashita M, et al. Effects of paraoxonase 1 on the cytodifferentiation and mineralization of periodontal ligament cells. J Periodont Res. 2018;53(2):200-9.
Chapple IL, Milward MR, Dietrich T. The prevalence of inflammatory periodontitis is negatively associated with serum antioxidant concentrations. J Nutr. 2007;137(3):657-64.
Figueredo CM, Gustafsson A, Asman B, Bergström K. Increased release of elastase from in vitro activated peripheral neutrophils in patients with adult periodontitis. J Clin Periodontol. 1999;26(4):206-11.
Chapple ILC, Matthews JB. The role of reactive oxygen and antioxidant species in periodontal tissue destruction. Periodontol 2000. 2007;43:160-232.
Ames BN, Shigenaga MK, Hagan TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A. 1993;90:7915-22.
Sculley DV, Langley-Evans SC. Periodontal disease is associated with lower antioxidant capacity in whole saliva and evidence of increased protein oxidation. Clin Sci. 2003;105:167-72.
Chapple ILC. The role of free radicals and antioxidants in the pathogenesis of the inflammatory periodontal diseases. Mol Pathol. 1996;49:M247-55.
Baskol G, Demir H, Çavdaroðlu B, Baþkol M, Koçer D. Assessment of praoxonase 1 activity and malondialdehyde levels in patients with osteoporosis. Erciyes Med J. 2007;29(4):268-73.
Teiber JF, Horke S, Haines DC, Chowdhary PK, Xiao J, Kramer GL, et al. Dominant role of paraoxonases in inactivation of the Pseudomonas aeruginosa quorum-sensing signal N-(3-oxododecanoyl)-L-homoserine lactone. Infect Immun. 2008;76(6):2512-9.
Li HL, Liu DP, Liang CC. Paraoxonase gene polymorphisms, oxidative stress, and diseases. J Mol Med. 2003;81:766-79.
Khersonsky O, Tawfik DS. Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase. Biochemistry. 2005;44(16):6371-82.
Litvinov D, Mahini H, Garelnabi M. Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases. North Am J Med Sci. 2012;4:523-32.
Ceron JJ, Tecles F, Tvarijonaviciute A. Serum paraoxonase 1 (PON1) measurement: an update. C Veter Res. 2014;10(74):4-11.
Draganov DI, La Du BN. Pharmacogenetics of paraoxonases: a brief review. Naunyn-Schmiedeberg Arch Pharmacol. 2004;369:78-88.
Noack B, Aslanhan Z, Boue´ J, Petig C, Teige M, Schaper F, et al. Potential association of paraoxonase-1, type 2 diabetes mellitus, and periodontitis. J Periodontol. 2013;84:614-23.
Chun CK, Ozer EA, Welsh MJ, Zabner J, Greenberg EP. Inactivation of a Pseudomonas aeruginosa quorum-sensing signal by human airway epithelia. Proceed Nat Acad Sci. 2004;101(10):3587-90.
Ozer EA, Pezzulo A, Shih MS, Chun C, Furlong C, Lusis AJ. Human and murine paraoxonase 1 are host modulators of Pseudomonas aeruginosa quorum-sensing. Federation of European Microbiological Societies. Microbiol Lett. 2005;253:29-37.
James RW. A long and winding road: defining the biological role and clinical importance of paraoxonases. Clin Chem Lab Med. 2007;44:1052-9.
Dong YH, Zhang LH. Quorum sensing and quorum quenching enzymes. J Microbiol. 2005;43:101-9.
Tóthová L’, Kamodyová N, Cervenka T, Celec P. Salivary markers of oxidative stress in oral diseases. Front Cell Infect Microbiol. 2015;5(73):1-23.
Patil PB, Patil BR. Saliva: a diagnostic biomarker periodontal diseases. J Indian Soc Periodontol. 2011;15(4):310-7.
Meisinger C, Freuer D, Bub A, Linseisen J. Association between inflammatory markers and serum paraoxonase and arylesterase activities in the general population: a cross sectional study. Lipids Health Dis. 2021;209(81):1-10.
Socransky SS, Haffajee AD, Cugini MA, Smith CM, Kent Jr RL. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998;25:134-44.
Tahir MK, Ab Malek AH, Vaithilingam RV, Saub R, Safii SH, Rahman MT, et al. Impact of non-surgical periodontal therapy on serum resistin and periodontal pathogen in periodontitis patients with obesity. BMC Oral Health. 2020;20(25):2-9.
Umeda M, Takeuchi Y, Noguchi K, Huang Y, Koshy G, Ishikawa I. Effects of nonsurgical l periodontal therapy on the microbiota. Periodontol 2000. 2004;36:98-120.
Chen MH, Yin HJ, Chang HH, Kao CT, Tu CC, Chen YW. Baseline probing depth and interproximal sites predict treatment outcomes of nonsurgical periodontal therapy. J Dent Sci. 2020;15:50-8.
Hamdi QA, Sarhat ER, Ali NH, Sarhat TR. Evaluation of lipocalin-2 and visfatin, and vitamin (D, C, and E) in serum of diabetic patients with chronic periodontitis. Indian J Forens Med Toxicol. 2021;15(2):1668-74.
Song J, Zheng Q, Ma X, Zhang Q, Xu Z, Zou C, et al. Expression levels of paraoxonase-1 in aortic valve tissue are associated with the progression of calcific aortic valve stenosis. J Thorac Dis. 2019;11(7):2890-8.
Furlonga CE, Suzuki SM, Stevens RC, Marsillach J, Richter RJ, Jarvik GP, et al. Human PON1, a biomarker of risk of disease and exposure. Chemico-Biol Interact. 2010;187;355-61.
Mackness B, Mackness MI, Arrol S, Turkie W, Julier K, Abuasha B, et al. Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in noninsulin dependent diabetes mellitus. Atherosclerosis. 1998;139(2):341-9.
Abbott CA, Mackness MI, Kumar S, Boulton AJ, Durrington PN. Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol. 1995;15(11):1812-8.
Ikeda Y, Suehiro T, Inoue M, Nakauchi Y, Morita T, Arii K, et al. Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus. Metabolism. 1998;47(5):598-602.
Shoeiba SA, Tawfeeka AR, Fathyb WM, Nouha MZ, El Kholya AM. Paraoxonase 1 enzyme activity in rheumatoid arthritis patients: association with carotid intima media thickness? Menoufia Med J. 2020;33:82-8.
Meisinger C, Freuerl D, Bub A, Linseisen J. Association between inflammatory markers and serum paraoxonase and arylesterase activities in the general population: a cross-sectional study. Lipids Health Dis. 2021;20(81):2-10.
Boehm D, Krzystek-Korpacka M, Neubauer K, Matusiewicz M, Berdowska I, Zielinski B, et al. Paraoxonase-1 status in Crohn’s disease and ulcerative colitis. Inflam Bowel Dis. 2009;15(1):93-9.
Précourt LP, Amre D, Denis MC, Lavoie JC, Delvinc E, Seidman ET. The three-gene paraoxonase family: physiologic roles, actions and regulation. Atherosclerosis. 2011;214:20-36.
Upadhyay A, Ramesh A. A comparative evaluation of serum paraoxonase enzyme in diabetes mellitus type ii patients and healthy individuals with and without periodontitis. World J Adv Scient Res. 2019;2(5):12-26.
